Back to Browse Journals » Journal of Blood Medicine » Volume 4

Beta-amyloidolysis and glutathione in Alzheimer's disease

Authors Lasierra-Cirujeda J, Coronel P, Aza MJ, Gimeno M

Published Date April 2013 Volume 2013:4 Pages 31—38

DOI http://dx.doi.org/10.2147/JBM.S35496

Received 29 June 2012, Accepted 4 December 2012, Published 15 April 2013

J Lasierra-Cirujeda,1 P Coronel,2 MJ Aza,3 M Gimeno2

1CM Hematológico SC, Logroño, La Rioja, Spain; 2Tedec-Meiji Farma, SA, Alcalá de Henares, Madrid, Spain; 3Pharmaceutical Act, Ministry of Health, Regional Government, La Rioja, Spain

Abstract: In this review, we hypothesized the importance of the interaction between the brain glutathione (GSH) system, the proteolytic tissue plasminogen activator (t-PA)/plasminogen/plasmin system, regulated by plasminogen activator inhibitor (PAI-1), and neuroserpin in the pathogenesis of Alzheimer's disease. The histopathological characteristic hallmark that gives personality to the diagnosis of Alzheimer's disease is the accumulation of neurofibroid tangles located intracellularly in the brain, such as the protein tau and extracellular senile plaques made primarily of amyloidal substance. These formations of complex etiology are intimately related to GSH, brain protective antioxidants, and the proteolytic system, in which t-PA plays a key role. There is scientific evidence that suggests a relationship between aging, a number of neurodegenerative disorders, and the excessive production of reactive oxygen species and accompanying decreased brain proteolysis. The plasminogen system in the brain is an essential proteolytic mechanism that effectively degrades amyloid peptides ("beta-amyloidolysis") through action of the plasmin, and this physiologic process may be considered to be a means of prevention of neurodegenerative disorders. In parallel to the decrease in GSH levels seen in aging, there is also a decrease in plasmin brain activity and a progressive decrease of t-PA activity, caused by a decrease in the expression of the t-PA together with an increase of the PAI-1 levels, which rise to an increment in the production of amyloid peptides and a lesser clearance of them. Better knowledge of the GSH mechanism and cerebral proteolysis will allow us to hypothesize about therapeutic practices.

Keywords: glutathione, Alzheimer's disease, t-PA, PAI-1, plasminogen

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Iron stores in regular blood donors in Lagos, Nigeria

Adediran A, Uche EI, Adeyemo TA, Damulak OD, Akinbami AA, Akanmu AS

Journal of Blood Medicine 2013, 4:75-80

Published Date: 10 June 2013

Serum ferritin levels in adults with sickle cell disease in Lagos, Nigeria

Akinbami AA, Dosunmu AO, Adediran AA, Oshinaike OO, Osunkalu VO, Ajibola SO, Arogundade OM

Journal of Blood Medicine 2013, 4:59-63

Published Date: 22 May 2013

Treatment of patients with von Willebrand disease [Erratum]

Tuohy E, Litt E, Alikhan R

Journal of Blood Medicine 2013, 4:57-58

Published Date: 20 May 2013

Lipid profile of regular blood donors

Uche EI, Adediran A, Damulak OD, Adeyemo TA, Akinbami AA, Akanmu AS

Journal of Blood Medicine 2013, 4:39-42

Published Date: 10 May 2013

A feasibility study of NIR fluorescent image-guided surgery in head and neck cancer based on the assessment of optimum surgical time as revealed through dynamic imaging

Yokoyama J, Fujimaki M, Ohba S, Anzai A, Yoshii R, Ito S, Kojima M, Ikeda K

OncoTargets and Therapy 2013, 6:325-330

Published Date: 8 April 2013

Biomarkers for the differentiation of anemia and their clinical usefulness

Northrop-Clewes CA, Thurnham DI

Journal of Blood Medicine 2013, 4:11-22

Published Date: 20 March 2013

Induction of oxidative stress, DNA damage, and apoptosis in a malignant human skin melanoma cell line after exposure to zinc oxide nanoparticles

Alarifi S, Ali D, Alkahtani S, Verma A, Ahamed M, Ahmed M, Alhadlaq HA

International Journal of Nanomedicine 2013, 8:983-993

Published Date: 7 March 2013

Use of sulodexide in patients with peripheral vascular disease

J Lasierra-Cirujeda, P Coronel, MJ Aza, et al

Journal of Blood Medicine 2010, 1:105-114

Published Date: 15 June 2010